<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kemung</surname>
    <given-names>H. M.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>L. T.-H.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>T. M.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>K.-G.</given-names>
   </name>
   <name>
    <surname>Pusparajah</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Goh</surname>
    <given-names>B.-H.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>
   <italic>Streptomyces</italic> as a prominent resource of future anti-MRSA drugs.
  </article-title>
  <source>
   <italic>Front. Microbiol.</italic>
  </source>
  <volume>9</volume>:
  <issue>2221</issue>. 
  <pub-id pub-id-type="doi">10.3389/fmicb.2018.02221</pub-id>
  <?supplied-pmid 30319563?>
  <pub-id pub-id-type="pmid">30319563</pub-id>
 </mixed-citation>
</ref>
